SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
Börse
USD
  • Johnson & Johnson
    Börse Börse Frankfurt
    ISIN US4781601046
    Symbol JNJ
    EUR
  • Johnson & Johnson
    Börse Börse Stuttgart
    Symbol JNJ
    EUR
  • Johnson & Johnson
    Börse Börse München
    Symbol JNJ
    EUR
  • Johnson & Johnson
    Börse Börse Berlin
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Xetra Frankfurt
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Gettex System der Börse München
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Tradegate System der Deutsche Börse AG (60%)
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Quotrix System der Börse Düsseldorf
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Börse Düsseldorf
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Börse Hamburg
    Symbol JNJ
    EUR
  • Johnson & Johnson
    Börse SGO
    USD
  • Johnson & Johnson
    Börse BUE
    USD
  • Johnson & Johnson
    Börse Bolsa de Comercio de Buenos Aires
  • Johnson & Johnson
    Börse Bolsa de Comercio de Buenos Aires
  • Johnson & Johnson
    Börse Bolsa de Comercio de Buenos Aires
  • Johnson & Johnson
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
  • Johnson & Johnson
    Börse SSE
Marktkapitalisierung 99.567.000.000
Mitarbeiter 141.700

Analystenmeinungen

Übersicht

Aktionärsstruktur der Johnson & Johnson

2.615 News & Informationen zur Johnson & Johnson Aktie

  • Futures Coiled Ahead Of J-Hole As China Slumps, Bitcoin Slides
    zerohedge.com

    Futures Coiled Ahead Of J-Hole As China Slumps, Bitcoin Slides

    ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero

  • Johnson & Johnson is recognized with the Best Places to Work Certification in Romania for 2021
    business-review.eu

    Johnson & Johnson is recognized with the Best Places to Work Certification in Romania for 2021

    Johnson & Johnson, the leading healthcare global company, is honored for recently being recognized and awarded as one of the best places to work in

  • Johnson & Johnson Files Application To Conduct Study On Its COVID Vaccine In Adolescents
    businessworld.in

    Johnson & Johnson Files Application To Conduct Study On Its COVID Vaccine In Adolescents

    Union Health Minister Mansukh Mandaviya had said the approval would further boost the country's collective fight against the novel coronavirus infection., , Johnson & Johnson, Covid vaccine, COVID-19 Vaccine

  • Japan Halts Use of 1.6 Million Moderna Shots on Debris Reports
    bloombergquint.com

    Japan Halts Use of 1.6 Million Moderna Shots on Debris Reports

    (Bloomberg) — Takeda Pharmaceutical Co Ltd. said it would suspend use of 1.63 million doses of Moderna Inc.’s Covid-19 vaccine in Japan after it received reports of foreign particles in the vials from several vaccination sites.

  • Orthopedic Navigation Systems Market Size Worth $6.05 Billion By 2028: Grand View Research, Inc.
    thestreet.com

    Orthopedic Navigation Systems Market Size Worth $6.05 Billion By 2028: Grand View Research, Inc.

    SAN FRANCISCO, Aug. 26, 2021 /PRNewswire/ –The global   orthopedic navigation systems market  size is expected to reach USD 6.05 billion by 2028, according to

  • Orthopedic Navigation Systems Market Size Worth $6.05 Billion By 2028: Grand View Research, Inc.
    prnewswire.com

    Orthopedic Navigation Systems Market Size Worth $6.05 Billion By 2028: Grand View Research, Inc.

    /PRNewswire/ — The global orthopedic navigation systems market size is expected to reach USD 6.05 billion by 2028, according to a new report by Grand View…

  • Professional Acne Treatment Market Worth $13,124.5 Million by 2030 says P&S Intelligence
    prnewswire.com

    Professional Acne Treatment Market Worth $13,124.5 Million by 2030 says P&S Intelligence

    /PRNewswire/ — From $6,298.9 million in 2020, the global professional acne treatment market value is predicted to reach $13,124.5 million by 2030, at a 7.6%…

  • What Is The Impact Of Choosing To Remain Unvaccinated Against Covid-19?
    forbes.com

    What Is The Impact Of Choosing To Remain Unvaccinated Against Covid-19?

    Delaying or refusing vaccines for non-medical reasons is literally a killer choice.

  • Wiener „female factor“ startet europäische Job-Plattform für Frauen
    derbrutkasten.com

    Wiener „female factor“ startet europäische Job-Plattform für Frauen

    The female factor ist eine in Wien gegründete Karriere-Community für Frauen. Die Job-Plattform lässt nur geprüfte Unternehmen zu.

  • COVID-19 vaccine tracker: Over 80 lakh doses administered in 24 hours; total coverage crosses 60 crore
    moneycontrol.com

    COVID-19 vaccine tracker: Over 80 lakh doses administered in 24 hours; total coverage crosses 60 crore

    On the 222nd day of the vaccination drive on August 25, 80,40,407 beneficiaries received the COVID jab

  • 2 Things Mainstream Media Didn’t Tell You About FDA’s Approval of the Pfizer Vaccine
    lewrockwell.com

  • Krispy Kreme Sweetens Its Free Doughnut Offer For Getting Covid-19 Vaccines
    forbes.com

    Krispy Kreme Sweetens Its Free Doughnut Offer For Getting Covid-19 Vaccines

    From August 30 through September 5, you can get not just one free doughnut but two. And the second doughnut is a little bit different.

  • UP Fintech (TIGR) falls 4.79% in Light Trading on August 25
    news.google.com

    UP Fintech (TIGR) falls 4.79% in Light Trading on August 25

    UP Fintech Holding Ltd – ADR (NASDAQ: TIGR) shares fell 4.79%, or $0.7 per share, to close Wednesday at $13.92. After opening the day at $14.12, shares of UP Fintech fluctuated between $14.34 and

  • U.S. likely to approve COVID-19 boosters at 6 months after vaccination
    marketwatch.com

    U.S. likely to approve COVID-19 boosters at 6 months after vaccination

    Federal regulators are likely to approve a COVID-19 booster shot for vaccinated adults starting at least six months after the previous dose rather than the…

  • U.S. plans COVID-19 booster shots at six months instead of eight - WSJ
    financialpost.com

    U.S. plans COVID-19 booster shots at six months instead of eight – WSJ

    U.S. health regulators could approve a third COVID-19 shot for adults beginning at least six months after full vaccination, instead of the previously announced…

  • FirstFT: ‘Real danger’ of terror attack at Kabul airport, Nato chief warns
    ft.com

    FirstFT: ‘Real danger’ of terror attack at Kabul airport, Nato chief warns

    Head of Nato warns of terror attack risk in Kabul, OnlyFans reverses porn ban, Japan and Taiwan to hold security talks

  • Outlook On The Multiple Myeloma Drugs Global Market To 2026 - By Therapy, Drug Type, End-user, Distribution Channel And Region
    thestreet.com

    Outlook On The Multiple Myeloma Drugs Global Market To 2026 – By Therapy, Drug Type, End-user, Distribution Channel And Region

    DUBLIN, Aug. 25, 2021 /PRNewswire/ — The “Multiple Myeloma Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”

  • U.S. set to approve COVID-19 booster shots at six months: WSJ
    economiccollapsenews.com

  • Johnson & Johnson : DePuy Synthes to Showcase Innovation Momentum at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting
    marketscreener.com

    Johnson & Johnson : DePuy Synthes to Showcase Innovation Momentum at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting

    Raynham, Mass., Aug. 25, 2021 — The Johnson & Johnson Medical Devices Companies* announced that DePuy Synthes,** The Orthopaedics Company of Johnson & Johnson, will feature new… | August 25, 2021

  • U.S. Stocks Close Higher Again; S&P, Nasdaq Climb To Fresh Record Highs
    rttnews.com

    U.S. Stocks Close Higher Again; S&P, Nasdaq Climb To Fresh Record Highs

    U.S. stocks closed higher on Wednesday, extending recent uptrend amid continued optimism about growth and on hopes the Federal Reserve might not begin tapering its bond-buying program anytime soon.

  • U.S. Stocks Close Higher Again; S&P, Nasdaq Climb To Fresh Record Highs
    markets.businessinsider.com

    U.S. Stocks Close Higher Again; S&P, Nasdaq Climb To Fresh Record Highs

    (RTTNews) – U.S. stocks closed higher on Wednesday, extending recent uptrend amid continued optimism about growth and on hopes the Federal Reserve…

  • DePuy Synthes to Showcase Innovation Momentum at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting
    prnewswire.com

    DePuy Synthes to Showcase Innovation Momentum at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting

    /PRNewswire/ — The Johnson & Johnson Medical Devices Companies* announced that DePuy Synthes,** The Orthopaedics Company of Johnson & Johnson, will feature…

  • Biden Will Promote Covid Boosters At 6 Months—Not 8, Report Says
    forbes.com

    Biden Will Promote Covid Boosters At 6 Months—Not 8, Report Says

    Around 77% of Americans are ready for their next shot, a poll found.

  • 2 Major Value Stock ETFs: An Analysis
    gurufocus.com

    2 Major Value Stock ETFs: An Analysis

    GuruFocus Article or News written by John Navin and the topic is about: A look at the iShares Russell 2000 Value ETF and the SPDR S&P 500 Value ETF

  • Nasdaq, S&P End at Records as Wall Street Awaits Fed's Jackson Hole Parley
    thestreet.com

    Nasdaq, S&P End at Records as Wall Street Awaits Fed's Jackson Hole Parley

    Stocks close at records again Wednesday as investors look ahead to a Federal Reserve gathering at the end of the week.

  • Moderna : U.S. plans COVID-19 booster shots at six months instead of eight - WSJ
    marketscreener.com

    Moderna : U.S. plans COVID-19 booster shots at six months instead of eight – WSJ

    U.S. health regulators could approve a
    third COVID-19 shot for adults beginning at least six months
    after full vaccination, instead of the previously announced
    eight-month gap, the Wall Street Journal… | August 25, 2021

  • COVID-19 vaccine boosters shots likely to be recommended by Biden administration after 6 months instead of 8, Wall Street Journal reports
    businessinsider.com

    COVID-19 vaccine boosters shots likely to be recommended by Biden administration after 6 months instead of 8, Wall Street Journal reports

    The Biden administration likely to recommend COVID-19 vaccine boosters 6 months after your second dose instead of the previously recommended 8 months.

  • Johnson & Johnson-Aktie Aktuell: Johnson & Johnson verzeichnet mit 0,8 Prozent Verluste
    rss.focus.de

    Johnson & Johnson-Aktie Aktuell: Johnson & Johnson verzeichnet mit 0,8 Prozent Verluste

    Der Anteilschein Pharmakonzern und Pharmakonzern Johnson & Johnson gehörte mit einem Rückgang von 0,8 Prozent zu den Verlierern des Tages. Bei Handelsende betrug der Preis des Anteilscheins 148,04 Euro.

  • What The FDA’s Approval Of The Pfizer Coronavirus Vaccine Means For Workers
    forbes.com

    What The FDA’s Approval Of The Pfizer Coronavirus Vaccine Means For Workers

    If these vaccines only had Emergency Use Authorizations, but they were readily available and employers could require their employees to take these vaccines, why does full approval of the Pfizer vaccine matter?

  • CIT GAP Funds Invests in BloomCatch to Advance the Next Generation of Horticultural Expertise
    globenewswire.com

    CIT GAP Funds Invests in BloomCatch to Advance the Next Generation of Horticultural Expertise

    Startup connects plant parents with plant experts and local retailers to keep their plants alive and happy…

  • Johnson & Johnson-Aktie Aktuell: Johnson & Johnson mit Kursverlusten von 0,8 Prozent
    rss.focus.de

    Johnson & Johnson-Aktie Aktuell: Johnson & Johnson mit Kursverlusten von 0,8 Prozent

    Die Aktie Pharmakonzern und Pharmakonzern Johnson & Johnson gehörte mit einer negativen Entwicklung von 0,8 Prozent zu den Verlustbringern des Tages. Bei Börsenschluss notierte der Anteilschein mit 148,04 Euro.

  • Best Healthcare Stocks to Buy in 2021
    investmentu.com

    Best Healthcare Stocks to Buy in 2021

    The best healthcare stocks might climb higher this year and much higher this decade. The healthcare industry continues to grow.

  • Developed countries urged to help poorer nations fight Covid
    ft.com

    Developed countries urged to help poorer nations fight Covid

    Low-income states still lack vaccine supplies and received just $21bn of $650bn IMF pandemic stimulus

  • Can my employer require me to get the COVID vaccine?
    adage.com

    Can my employer require me to get the COVID vaccine?

    The short answer: Yes. But there's more, and we answer all your questions.

  • More Than Three-Quarters Of Vaccinated Americans Plan To Get Covid-19 Booster Shot, Poll Finds
    forbes.com

    More Than Three-Quarters Of Vaccinated Americans Plan To Get Covid-19 Booster Shot, Poll Finds

    A further 6% said they’ve already gotten an extra dose, reflecting the fact many are already getting them against public health advice.

  • More Than Three-Quarters Of Vaccinated Americans Plan To Get Covid-19 Booster Shot, Poll Finds
    forbes.com

    More Than Three-Quarters Of Vaccinated Americans Plan To Get Covid-19 Booster Shot, Poll Finds

    A further 6% said they’ve already gotten an extra dose, reflecting the fact many are already getting them against public health advice.

  • Billa, Billa Plus und Penny starten Corona-Impfung
    derbrutkasten.com

    Billa, Billa Plus und Penny starten Corona-Impfung

    Im Kampf gegen das Coronavirus setzt Österreich verstärkt auf niederschwellige Impfangebote ohne Terminvereinbarung. In Wien kann man sich nun auch an der Supermarkt-Kassa bei Billa, Billa Plus und Penny immunisieren lassen.

  • Casey's General Stores, Inc., Selects Momentive To Power Experience Management And Market Research
    thestreet.com

    Casey's General Stores, Inc., Selects Momentive To Power Experience Management And Market Research

    SAN MATEO, Calif., Aug. 25, 2021 (GLOBE NEWSWIRE) — Momentive (NASDAQ: MNTV—formerly SurveyMonkey), a leader in agile experience management, today announced

  • Casey’s General Stores, Inc., selects Momentive to power experience management and market research
    globenewswire.com

    Casey’s General Stores, Inc., selects Momentive to power experience management and market research

    Momentive solutions enable Casey’s to measure employee feedback, gauge product awareness, understand consumer behavior and preferences, and shape new…

  • Johnson&Johnson: Booster-Impfung nach 8 Monaten erhöht Antikörper
    businessinsider.de

    Johnson&Johnson: Booster-Impfung nach 8 Monaten erhöht Antikörper

    Das Unternehmen teilte mit, dass die Antikörperwerte nach der Booster-Impfung neunmal höher waren als nach der Einzeldosis des Impfstoffs.

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Johnson & Johnson Aktie

Das Unternehmen Johnson & Johnson aus USA beschäftigt 141.700 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Medizinische Produkte / Medizintechnik, Drogerie & Kosmetik, Biotechnologie, Pharma tätig.

Johnson & Johnson ist in ungefähr 18 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter UBS ETF (IE) Factor  MSCI USA  Quality  UCITS  ETF (hedged to CHF) A-acc gewichtet Johnson & Johnson mit 4,34% im ETF.

Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Johnson & Johnson Anleihen auf einen Blick.

Entdecke die 6 ETFs in denen Johnson & Johnson am höchsten gewichtet ist Insgesamt in 18 ETFs enthalten

Dir gefallen die Informationen zu Johnson & Johnson?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Johnson & Johnson?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Johnson & Johnson?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Johnson & Johnson?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic